Ovarian adenocarcinoma
Ovarian Adenocarcinoma
Ovarian adenocarcinoma is a type of cancer that originates from the cells in the ovary. It is the most common type of ovarian cancer, accounting for about 90% of all ovarian cancers.
Etiology[edit | edit source]
The exact cause of ovarian adenocarcinoma is unknown. However, several risk factors have been identified, including age, family history of ovarian or breast cancer, certain genetic mutations (BRCA1 and BRCA2), and long-term use of hormone replacement therapy.
Pathophysiology[edit | edit source]
Ovarian adenocarcinoma begins in the epithelial cells, which are the outer layer of cells that cover the ovaries. These cells can undergo changes that lead to uncontrolled growth and the formation of a tumor. If not detected and treated early, the tumor can spread to other parts of the body, a process known as metastasis.
Symptoms[edit | edit source]
Early-stage ovarian adenocarcinoma often causes no symptoms. As the disease progresses, symptoms may include abdominal bloating or swelling, pelvic pain, loss of appetite, and changes in bowel or bladder habits.
Diagnosis[edit | edit source]
Diagnosis of ovarian adenocarcinoma typically involves a combination of physical examination, imaging tests such as ultrasound or CT scan, and blood tests to measure levels of a protein called CA-125, which is often elevated in women with ovarian cancer. A definitive diagnosis is usually made by performing a biopsy of the tumor.
Treatment[edit | edit source]
Treatment for ovarian adenocarcinoma depends on the stage of the disease and the patient's overall health. Options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, or a combination of these.
Prognosis[edit | edit source]
The prognosis for ovarian adenocarcinoma varies depending on the stage at diagnosis, the patient's age and overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve the prognosis.
See Also[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
This gynecology related article is a stub. You can help WikiMD by expanding it.
 | This Women's health article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
